FDA: Purveyors of phony botox targeting U.S. practices
(HealthDay)—Medical practices that purchase Botox may unwittingly be purchasing a fraudulent product not approved by the U.S. Food and Drug Administration for sale in the United States, according to an ...
Medications
Apr 29, 2013 |
not rated yet |
0
FDA announces new network to focus exclusively on patients
(HealthDay)—The U.S. Food and Drug Administration has announced the launch of a new interactive tool for educating patients, their advocates, and consumers about the processes involved in medication development.
Medications
Apr 29, 2013 |
not rated yet |
0
FDA rejects two HIV drugs from Gilead Sciences
Gilead Sciences Inc. says that the Food and Drug Administration rejected two marketing applications for HIV treatments, citing quality control problems at the company's manufacturing facilities.
Medications
Apr 29, 2013 |
1 / 5 (1) |
0
Tart cherries linked to reduced risk of stroke
(Medical Xpress)—For the millions of Americans at risk for heart disease or diabetes, a diet that includes tart cherries might actually be better than what the doctor ordered, according to new animal research ...
Health
Apr 24, 2013 |
3.8 / 5 (4) |
0
|
Indianapolis pharmacy recalls compounded drugs
(AP)—A pharmacy that makes specialty medications is recalling nearly 100 compounded drugs after federal regulators found potential safety problems during an inspection.
Medications
Apr 23, 2013 |
not rated yet |
0
Fla. compounding pharmacy recalls sterile drugs
A Florida-based compounding pharmacy is voluntarily recalling all lots of its sterile non-expired drug products sold nationwide over concerns the products are not sterile and may contain bacteria.
Medications
Apr 21, 2013 |
not rated yet |
0
Study says more efforts needed to regulate dietary supplements
Dietary supplements accounted for more than half the Class 1 drugs recalled by the U.S. Food and Drug Administration from 2004-12, meaning they contained substances that could cause serious health problems or even death, ...
Health
Apr 18, 2013 |
not rated yet |
0
Despite superbug crisis, progress in antibiotic development 'alarmingly elusive'
Despite the desperate need for new antibiotics to combat increasingly deadly resistant bacteria, the U.S. Food and Drug Administration (FDA) has approved only one new systemic antibiotic since the Infectious Diseases Society ...
Diseases, Conditions, Syndromes
Apr 18, 2013 |
not rated yet |
0
FDA approves Phase II of stem cell trial for ALS
For nearly two years, University of Michigan neurologist Eva Feldman, M.D., Ph.D. has led the nation's first clinical trial of stem cell injections in patients with the deadly degenerative disease known as amyotrophic lateral ...
Medical research
Apr 17, 2013 |
not rated yet |
0
Fearing abuse, US blocks generic OxyContin (Update)
U.S. health regulators will require generic versions of the best-selling painkiller OxyContin to include recent formulation changes designed to make the pill harder to abuse.
Medications
Apr 16, 2013 |
not rated yet |
1
New study finds digoxin safe despite recent reports
A study published today in the European Heart Journal found no evidence that digoxin increases mortality in patients with atrial fibrillation (AF), the opposite of results just published by another group in the same journa ...
Cardiology
Apr 16, 2013 |
not rated yet |
0
|
FDA warns consumers of dangers of the stimulant DMAA
(HealthDay)—The U.S. Food and Drug Administration is attempting to halt distribution of dietary supplements that contain the stimulant dimethylamylamine (DMAA), following reports of illness and death associated ...
Health
Apr 15, 2013 |
5 / 5 (2) |
0
FDA reviewing heart risks of Glaxo diabetes pill
(AP)—The Food and Drug Administration will hold a meeting in June to reassess the safety of GlaxoSmithKline's former blockbuster diabetes drug Avandia.
Medications
Apr 12, 2013 |
not rated yet |
0
FDA cites sanitary issues at specialty pharmacies
(AP)—The Food and Drug Administration says it has uncovered troubling sterility problems at 30 specialty pharmacies that were inspected following a recent outbreak of meningitis caused by contaminated drugs.
Health
Apr 12, 2013 |
not rated yet |
0
US court orders wider access for morning-after pill (Update 2)
After a decade-long battle over access to emergency contraception, a federal judge ordered US regulators Friday to make the morning-after pill available over the counter without age limits.
Medications
Apr 05, 2013 |
not rated yet |
0
